TBXU
Direxion Daily Biotech Top 5 Bull 2X ETF
TBXU
Closed
$33.13
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
TBXU was created on 2025-10-01 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry.
Company
Direxion
Asset class
Equity
Inception date
2025
Investment segment
Health Care
ISIN
US25461H1014
Website
Key stats
Open
$34.19
Volume
115.00
AUM
$3.38M
Prev. close
$33.53
Expense ratio
0.98%
P/E
0.00
$34.19
Day’s Range
$34.19
$27.00
52W Range
$37.69
What’s in the fund
11
Total holdings
Dreyfus Govt Cash Man Ins
23.88%
Goldman Finl Sq Trsry Inst 506
21.84%
Vertex Pharmaceuticals Inc
8.97%
Regeneron Pharmaceuticals Inc
7.98%
Amgen Inc
7.79%
Gilead Sciences Inc
7.78%
argenx SE ADR
7.73%
Dx D Biotech T 5 Bull 2x Etf Swap
5.91%
Goldman Sachs Fin Gov 465 Institut
4.63%
Others
3.49%
Returns
Performance
_
Difference
_
Direxion Daily Biotech Top 5 Bull 2X ETF
Jun
30
Dividends
The last payment date was Jun 30, 2026
Div. per Share
$0.11
Div. Yield
0.33%
Div. Growth YoY
12.21%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply